Search by Drug Name or NDC

    NDC 51655-0714-52 levothyroxine sodium 175 ug/1 Details

    levothyroxine sodium 175 ug/1

    levothyroxine sodium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is LEVOTHYROXINE SODIUM.

    Product Information

    NDC 51655-0714
    Product ID 51655-714_db5de856-c80a-2add-e053-2a95a90a9b13
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name levothyroxine sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name levothyroxine sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 175
    Active Ingredient Units ug/1
    Substance Name LEVOTHYROXINE SODIUM
    Labeler Name Northwind Pharmaceuticals
    Pharmaceutical Class Thyroxine [CS], l-Thyroxine [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021116
    Listing Certified Through 2024-12-31

    Package

    NDC 51655-0714-52 (51655071452)

    NDC Package Code 51655-714-52
    Billing NDC 51655071452
    Package 30 TABLET in 1 BOTTLE, PLASTIC (51655-714-52)
    Marketing Start Date 2021-05-26
    NDC Exclude Flag N
    Pricing Information N/A